Abcalis© SARS-CoV-2 antibodies
Abcalis® anti-SARS-CoV-2 antibodies are high quality recombinant monoclonal primary antibodies
Abcalis product portfolio now also features anti-SARS-CoV-2 recombinant (sequence defined) monoclonal antibodies. Currently, we are offering a variety of different clones with specificities to the S1-, S1+S2-, RBD- as well as N-protein and can work with them in different projects for different applications.
The solutions from and with Abcalis are qualified to meet regulatory standards and criteria even in the long term, as is the standard with all Abcalis products, since they are all completely sequence defined, implying their unlimited long-term availability and always identical test results. This allows for a much lower unspecific binding reactivity in many assays compared to animal based products.
Simply contact us with your specific needs or request for your setup and we will gladly explore possibilities together!